CIA
TNDM icon

CSat Investment Advisory’s Tandem Diabetes Care TNDM Stock Holding History

CSat Investment Advisory’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-374
Closed -$42K – 920
2020
Q3 		$42K Buy
374
+43
+13% +$4.52K ﹤0.01% 693
2020
Q2 		$33K Buy
+331
New +$26.4K ﹤0.01% 735

Other funds holding TNDM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CSat Investment Advisory's TNDM Position: Q4 2020 in Review

CSat Investment Advisory sold out of Tandem Diabetes Care (TNDM) in Q4 2020, closing a stake of 374 shares — an estimated $42K sold.

CSat Investment Advisory first reported a position in TNDM in Q2 2020 and held it in 2 quarters. The position peaked at $42K in Q3 2020. 309 funds tracked by Wall St. Rank hold TNDM as of Q4 2020.

  • CSat Investment Advisory reported no remaining Tandem Diabetes Care position as of Q4 2020 after selling out during the quarter.
  • CSat Investment Advisory sold 374 Tandem Diabetes Care shares in Q4 2020, an estimated $42K.
  • CSat Investment Advisory first reported a position in Tandem Diabetes Care in Q2 2020 and held it in 2 quarters.
  • CSat Investment Advisory's Tandem Diabetes Care position peaked at $42K in Q3 2020.
  • 309 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.